Wednesday, July 8, 2026
🇺🇸 FDA

biotech · Chronic Hepatitis b · Hepatitis B, Chronic · ABUS

Arbutus Biopharma

Arbutus Biopharma Corp

Arbutus Biopharma patent portfolio — 56 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
701 Veterans Circle, Warminster, Pennsylvania 18974, US HQ
49 Employees
Public company Type
ABUS · NYSE Ticker
Company details
Status
Public
HQ
701 Veterans Circle, Warminster, Pennsylvania 18974, US
Employees
49
Programs
13
Drugs
7
Patents
56
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Arbutus Biopharma patents

56 pharmaceutical patents indexed for Arbutus Biopharma. 0 expire within 24 months.

Arbutus Biopharma has 56 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

56 patents

Patent portfolio

Page 1 of 2

  1. US 12357705

    Negatively charged peg-lipid conjugates

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12350383

    Cationic lipids containing silicon

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12251470

    Lipid nanoparticle formulations

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12129467

    Non-liposomal systems for nucleic acid delivery

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12083118

    Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12043833

    Targeted compositions

    Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12042541

    Lipids and compositions for the delivery of therapeutics

    Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12023383

    Lipid compositions

    Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12016929

    Lipid formulations for delivery of therapeutic agents

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11904052

    Methods for ameliorating infusion reactions

    Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11896672

    Targeted nucleic acid conjugate compositions

    Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11786598

    Lipid formulations for delivery of therapeutic agents

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11718852

    Non-liposomal systems for nucleic acid delivery

    Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11712476

    Lipids and compositions for the delivery of therapeutics

    Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11702427

    Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same

    Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11566002

    Substituted tetrahydrocyclopenta[C]pyrroles, substituted dihydropyrrolizines, analogues thereof, and methods using same

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11505551

    Methods for preparing substituted pyridinone-containing tricyclic compounds

    Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11446383

    Lipid formulations for delivery of therapeutic agents

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11427823

    Targeted compositions

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11420931

    Lipid containing formulations

    Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11395854

    Trialkyl cationic lipids and methods of use thereof

    Expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11351118

    Methods for ameliorating infusion reactions

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11318098

    Liposomal apparatus and manufacturing methods

    Expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11298320

    Liposomal apparatus and manufacturing methods

    Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11191849

    Compositions and methods for delivering messenger RNA

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11141378

    Lipid formulations for nucleic acid delivery

    Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11130740

    Substituted 2,3-dihydro-1H-indene analogs and methods using same

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11098010

    Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same

    Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11077197

    Lipids and compositions for the delivery of therapeutics

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11013726

    Substituted pyridinone-containing trycyclic compounds, and methods using same

    Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11001564

    Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same

    Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10953095

    Lipid compositions

    Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10835612

    Lipids and compositions for the delivery of therapeutics

    Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10821186

    Lipids and compositions for the delivery of therapeutics

    Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10821103

    Substituted pyridinone-containing trycyclic compounds, and methods using same

    Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10653780

    Amino lipids and methods for the delivery of nucleic acids

    Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10626393

    Delivering CRISPR therapeutics with lipid nanoparticles

    Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10561732

    Trialkyl cationic lipids and methods of use thereof

    Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10550084

    Substituted 1-hydroxy-pyridin-2(1H)-ones, and methods of making and using same

    Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10456473

    Lipid compositions

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10415037

    Compositions and methods for silencing hepatitis B virus gene expression

    Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10358447

    Substituted 2-N-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same

    Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10117941

    Lipids and compositions for the delivery of therapeutics

    Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10077232

    Cyclic cationic lipids and methods of use

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10053689

    Methods for increasing efficacy of lipid formulated siRNA

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9938236

    Antiviral agents against HBV infection

    Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9895448

    Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components

    Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9814777

    Targeting lipids

    Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Arbutus Biopharma have?

56 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Arbutus Biopharma patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.